共 50 条
- [42] Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (07): : 447 - 461
- [43] Efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with acute heart failure: a systematic review and meta-analysis FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
- [49] Commentary: Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
- [50] Long-term surrogate cardiovascular outcomes of SGLT2 inhibitor empagliflozin in chronic heart failure: a systematic review and meta-analysis BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):